| Literature DB >> 28918412 |
Thomas Desautels1, Ritankar Das1, Jacob Calvert1, Monica Trivedi2, Charlotte Summers3, David J Wales4, Ari Ercole3.
Abstract
OBJECTIVES: Unplanned readmissions to the intensive care unit (ICU) are highly undesirable, increasing variance in care, making resource planning difficult and potentially increasing length of stay and mortality in some settings. Identifying patients who are likely to suffer unplanned ICU readmission could reduce the frequency of this adverse event.Entities:
Keywords: machine learning; prediction; unplanned readmission
Mesh:
Year: 2017 PMID: 28918412 PMCID: PMC5640090 DOI: 10.1136/bmjopen-2017-017199
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Transfers undergone by an example class 1 patient. In this example, a patient is admitted to the hospital via the ED, which is classed as a non-ICU-type unit. From the ED, the patient is transferred to an ICU-type unit. After some time in the ICU, the patient is transferred down to a ward (a non-ICU-type unit), but within the next 48 hours, the patient is transferred back to the ICU. The patient survives, and is ultimately discharged. Since the patient’s first ICU stay was followed by another ICU stay, starting less than 48 hours later, this patient is given a class 1 (failed down-transfer) label under the gold standard definition. When training or providing test predictions, the patient’s condition at the time of the first down-transfer from the ICU is used to predict this label. ED, emergency department; ICU, intensive care unit.
Figure 2Exclusion diagram. Individual hospital admissions are screened to produce a final data set (n=2018; 88 class 1; 1930 class 0; 4.36% prevalence). HDU, high dependency unit; ICU, intensive care unit.
Demographic information for the final study population, all of whom were ICU patients at CUH. The final study population was somewhat more heavily male than female. Among those who were readmitted to the ICU, the distribution of this second ICU stay’s length skewed strongly to the right (towards longer, second ICU stays)
| Total patients | 2018 |
| Male | 1230 (60.95%) |
| Age: mean (SD) (years) | 55.43 (19.08) |
| Age: median (IQR) | 57.00 (42.00, 70.00) |
| Total hospital length of stay: mean (SD) (days) | 27.44 (31.19) |
| Total hospital length of stay: median (IQR) (days) | 18.04, IQR (9.16, 33.42) |
| First ICU: Neurosciences | 1255 (62.19%) |
| First ICU: General | 763 (37.81%) |
| Patients with class 1 gold standard (death or ICU readmission within 48 hours of down-transfer from ICU) | 88 (4.36%) |
| Time from down-transfer to death or ICU readmission: mean (SD) (hours) | 16.24 (15.40) |
| Time from down-transfer to death or ICU readmission: median (IQR) (hours) | 9.65, IQR (2.49, 29.43) |
| Patients who died before ICU readmission | 21 |
| Patients who began second ICU stay | 67 |
| Patients who died at the end of this second ICU stay | 2 |
| Duration of second ICU stay: mean (SD) (hours) | 122.06 (150.77) |
| Duration of second ICU stay: median (IQR) (hours) | 66.53, IQR (23.52, 144.58) |
CUH, Cambridge University Hospitals NHS Foundation Trust; ICU, intensive care unit.
Performance characteristics for the trained ensembles and SWIFT. CUH, Cambridge University Hospitals NHS Foundation Trust; MIMIC III, Medical Information Mart for Intensive Care; SWIFT, Stability and Workload Index for Transfer.
| Ensemble: transfer | Ensemble: MIMIC-III only | Ensemble: CUH only | SWIFT | |
| AUROC |
| 0.6079 (0.0256) | 0.6092 (0.0320) | 0.6082 (0.0786) |
| Sensitivity | 0.5917 | 0.5792 |
| 0.5682 |
| Specificity |
| 0.5700 | 0.5030 | 0.6234 |
| F1 |
| 0.1074 | 0.0956 | 0.1156 |
| DOR |
| 1.8243 | 1.5007 | 2.1780 |
| Brier score |
| 0.1830 (0.0048) | 0.0462 (0.0015) | NA |
AUROC and Brier score are presented as mean (SE) over 10 cross-validation folds. All characteristics other than AUROC and Brier score are computed from a particular operating point on the ROC curves (figure 2) and prevalence; this operating point is chosen such that sensitivity is the highest available value less than or equal to 0.60. The best value for each performance measure is in bold.
AUROC, area under the receiver operating characteristic curve; Brier score, mean square forecast error, where the forecast is the probabilistic output of the classifier; CUH, Cambridge University Hospitals NHS Foundation Trust; DOR, diagnostic OR, the ratio of true positives to positive test results, divided by the ratio of true negatives to negative test results; F1, two times the harmonic mean of precision and sensitivity (recall), where precision is the ratio of true positives to the sum of true positives and false positives; NA, not applicable; Sensitivity, the ratio of detected positive examples to all positive examples; Specificity, the ratio of true negatives to the sum of true negatives and false positives.
Figure 3ROC curves for prediction performance on CUH test data. The choice of detection threshold determines a trade-off between sensitivity (true positive rate) and 1−specificity (false positive rate). The superiority of the transfer-learning-trained ensemble (solid) over SWIFT is clear throughout the operating regime, except at the very low-sensitivity, high-specificity portion of the curve (far left), where they perform similarly. CUH, Cambridge University Hospitals NHS Foundation Trust; ROC, receiver operating characteristic curve; MIMIC III, Medical Information Mart for Intensive Care; SWIFT, Stability and Workload Index for Transfer.
Figure 4Target test set AUROC changes with mixture weight w (the proportion of total training example weight allocated to CUH examples). The results shown in figure 3 are at the left (MIMIC-III only) and right (CUH only) extremes of this interval, and at the peak of the curve (optimal transfer mixture weight). Equal per-example weighting corresponds to w=0.043; the maximal w value of 0.075 indicates that target examples are indeed more informative than source examples. AUROC, area under the receiver operating characteristic curve; CUH, Cambridge University Hospitals NHS Foundation Trust; MIMIC III, Medical Information Mart for Intensive Care.